Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Journal of Sleep Research
|
August 13, 2014
Efavirenz modulation of sleep spindles and sleep spectral profile
Arthur A Simen, Junshui Ma, Vladimir Svetnik, et al.
Journal of Clinical Pharmacology
|
October 15, 2013
Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients
Hong Sun, Catherine MacLeod, Kate Mostoller, et al.
Bioanalysis
|
June 28, 2024
Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffs
Arpita Choudhury, Yuhua Zhang, Junshui Ma, et al.
The Lancet. Oncology
|
June 8, 2018
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X Zhu, Richard S Finn, Julien Edeline, et al.
The Journal of Pathology. Clinical Research
|
April 17, 2024
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119
Javier Cortes, Eric P Winer, Oleg Lipatov, et al.
Neuropsychobiology
|
April 4, 2013
Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG)
Marc Jobert, Frederick J Wilson, Thomas Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
Aude Fléchon, Rafael Morales-Barrera, Thomas Powles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Joaquim Bellmunt, Ronald de Wit, Yves Fradet, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Journal of Sleep Research
|
August 13, 2014
Efavirenz modulation of sleep spindles and sleep spectral profile
Arthur A Simen, Junshui Ma, Vladimir Svetnik, et al.
Journal of Clinical Pharmacology
|
October 15, 2013
Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients
Hong Sun, Catherine MacLeod, Kate Mostoller, et al.
Bioanalysis
|
June 28, 2024
Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffs
Arpita Choudhury, Yuhua Zhang, Junshui Ma, et al.
The Lancet. Oncology
|
June 8, 2018
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X Zhu, Richard S Finn, Julien Edeline, et al.
The Journal of Pathology. Clinical Research
|
April 17, 2024
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119
Javier Cortes, Eric P Winer, Oleg Lipatov, et al.
Neuropsychobiology
|
April 4, 2013
Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG)
Marc Jobert, Frederick J Wilson, Thomas Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
Aude Fléchon, Rafael Morales-Barrera, Thomas Powles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Joaquim Bellmunt, Ronald de Wit, Yves Fradet, et al.
Page
of 3